Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

.gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Clinicalinfo.HIV.gov logo.
In affiliation with HIV.gov
Main navigation
  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • English
  • Español (Spanish)
  1. Home
  2. Guidelines search

Search Guidelines

  • (-) Perinatal HIV Clinical Guidelines (93)
  • HIV Clinical Guidelines: Pediatric ARV (84)
  • HIV Clinical Guidelines: Adult and Adolescent ARV (67)
  • HIV Clinical Guidelines: Pediatric Opportunistic Infections (44)
  • HIV Clinical Guidelines: Adult and Adolescent Opportunistic Infections (40)
  • Guidance for Caring for People With HIV Displaced by Disasters (4)
Search Results 21 – 40 of 93
Lack of Viral Suppression While on Antiretroviral Therapy in Pregnancy
Table 6. What to Start: Initial Antiretroviral Regimens During Pregnancy
Table 7. Situation-Specific Recommendations for Use of Antiretroviral Drugs During Pregnancy and When Trying to Conceive
Teratogenicity
Antiretroviral Drug Regimens and Pregnancy Outcomes
Special Populations
Hepatitis B Virus/HIV Coinfection
Hepatitis C Virus/HIV Coinfection
HIV-2 and Pregnancy
Prenatal Care, Antiretroviral Therapy, and HIV Management When HIV Was Perinatally Acquired
Early (Acute and Recent) HIV Infection
Intrapartum HIV Care
Postpartum HIV Management and Follow-Up
Preventing HIV Transmission During Infant Feeding
Care of Infants With Perinatal Exposure to HIV
Antiretroviral Management of Infants With In Utero, Intrapartum, or Breastfeeding Exposure to HIV
Diagnosis of HIV Infection in Infants and Children
Initial Postnatal Management of the Neonate Exposed to HIV
Long-Term Follow-Up of Infants Exposed to Antiretroviral Drugs
Appendix A: Key to Acronyms

Pagination

  • First page ‹‹
  • Previous page ‹
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Next page ›
  • Last page ››

CONNECT WITH US

Footer menu

  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • Sponsors
  • Nondiscrimination Notice
  • Accessibility
  • Disclaimers
  • Sitemap
  • Privacy Policy
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.